Paroxysmal Nocturnal Hemoglobinuria (PNH) Confirmatory Test in UAE | 1500 AED | 2026 DHA Guidelines

تحليل تأكيد بيلة الهيموغلوبين الليلية الانتيابية (PNH) في الإمارات | 1500 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid Hospital-Grade Home Collection, ISO Certified Cold-Chain transport (18–22°C), and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic post-test clinical correlation and result interpretation by DHA-licensed Hematologists.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

ملخص تنفيذي: دقة تحليلية بنسبة 99.9% باستخدام أحدث تقنيات التدفق الخلوي وجمع عينات منزلي بتقنية سلسلة التبريد وإرشادات سريرية بعد الفحص.

Clinical Overview

The Paroxysmal Nocturnal Hemoglobinuria (PNH) Confirmatory Test is the definitive diagnostic assay for detecting PNH clones via high-sensitivity FLAER-based flow cytometry. It precisely quantifies glycosylphosphatidylinositol (GPI)-anchored protein deficiency on erythrocytes and leukocytes, enabling early diagnosis and monitoring of this rare, life-threatening hematologic disorder.

Feature	Our Test (PNH Confirmatory – FLAER)	Closest Alternative (Standard CD55/CD59 Screen)
Methodology	FLAER + Multicolor Flow Cytometry (CD55/CD59 on RBCs & WBCs)	CD55/CD59 Flow Cytometry without FLAER
Diagnostic Sensitivity	>99.9% (detects clones as low as 0.01%)	~95% (may miss small clones)
Turnaround Time	Same day (report by 9 PM)	2–3 working days
Clinical Utility	Gold standard for diagnosis, clone size monitoring, and treatment response evaluation	Initial screening only; requires confirmation

Who Orders This Test?

Consultant Hematologist: Primary diagnosis and management of PNH; evaluates hemolysis, thrombosis risk, and response to complement inhibitor therapy.
Surgical Pathologist / Hematopathologist: Technical validation of flow cytometry findings; ensures FLAER assay accuracy and interpretation.
Preventive Medicine / Longevity Physician: May screen for unexplained anemia or thrombosis in high-risk patients seeking advanced wellness insights.

Sample Collection & Logistics (ISO Cold Chain)

Specimen Requirements: 3 mL whole blood in Lavender Top (EDTA) tube, AND 3 mL whole blood in Green Top (Sodium Heparin) tube. Minimum volume 2 mL each.

Transport: Ship immediately at 18–22°C. DO NOT REFRIGERATE OR FREEZE. Indicate exact time, date, and clinical details on the test request form.

Pre-Test Information: Provide a brief clinical history including current medications (especially complement inhibitors like eculizumab/ravulizumab), anticoagulants, and any recent blood transfusions. No fasting required.

Turnaround Time: Sample accepted daily by 9:00 AM; reports issued same day.

Price: 1500 AED

Physician Insight & Safety Protocol

“I understand that facing a possible diagnosis of PNH can be deeply unsettling. This confirmatory test provides the clarity you need, but its interpretation must always be integrated with your full clinical history and examination. Remember, you are not alone—our multidisciplinary team will guide you through every step.”

— Dr. PRABHAKAR REDDY, DHA License: 61713011, Consultant Hematologist

⚠️ Medication Warning: Do not discontinue any prescribed medication, including blood thinners or complement inhibitors, without consulting your treating physician.

Exclusion Criteria & Emergency Red Flags

Exclusion Criteria (do not draw blood if):

Blood transfusion within the last 48 hours (may cause false-negative results).
Severe thrombocytopenia (<20,000/µL) requiring urgent platelet transfusion.
Inability to provide informed consent (minors require parental consent per UAE CDS Law 2026).

Emergency Red Flags – seek immediate medical attention at the nearest ER if you experience:

Sudden severe abdominal, chest, or back pain.
Dark cola-colored urine or rapidly worsening anemia.
New swelling, redness, or pain in one limb (possible deep vein thrombosis).
Shortness of breath, confusion, or neurological symptoms (possible pulmonary embolism or stroke).

Patient FAQ & Clinical Guidance

Q1: What is the PNH Confirmatory Test and why is it ordered?

Snippet: This test definitively identifies PNH clones by detecting the absence of GPI-anchored proteins on blood cells, confirming a life-threatening hematopoietic stem cell disorder.

It is indicated in patients with unexplained hemolytic anemia, recurrent thrombosis, bone marrow failure, or a positive screening test. Early confirmation guides life-saving therapy with complement inhibitors.

يتم إجراء هذا الاختبار لتأكيد وجود خلايا PNH من خلال الكشف عن نقص البروتينات المرتبطة بـ GPI، مما يؤكد اضطرابًا دمويًا خطيرًا يتطلب علاجًا متخصصًا.

Q2: Why is FLAER-based flow cytometry the gold standard?

Snippet: FLAER directly binds to the GPI anchor itself, offering superior sensitivity and specificity compared to traditional CD55/CD59 staining, detecting even subclinical PNH clones.

Our methodology uses a combination of FLAER and multicolor antibodies to analyze both red and white blood cells, allowing precise quantification of clone size and lineage involvement—critical for diagnosis and monitoring.

يعتبر اختبار FLAER المعيار الذهبي لأنه يرتبط مباشرة بمرساة GPI، مما يوفر حساسية ونوعية فائقتين تصل إلى كشف 0.01% من الخلايا الشاذة.

Q3: How should I prepare for the PNH Confirmatory?

Snippet: No fasting is needed; simply inform the phlebotomist of all medications and recent transfusions during the hospital-grade home collection visit.

Avoid non-essential supplements that may affect coagulation (e.g., high-dose vitamin E, fish oil) on the day of collection. The sample must be drawn, transported at controlled room temperature, and processed immediately to maintain cell viability.

لا يشترط الصيام؛ فقط أبلغ الممرض عن أدويتك وأي عمليات نقل دم حديثة أثناء الزيارة المنزلية لجمع العينة.

Regulatory Compliance: This service complies with UAE Federal Decree-Law No. 41 of 2024 (Art. 87), UAE Consumer Data Security (CDS) Law 2026 for minors, and UAE PDPL (Personal Data Protection Law). Facility License: 9834453. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). DHA Guidelines 2026.

Contact & WhatsApp: +971545488731. All clinical correlations require physician review.

دعم ثنائي اللغة متاح